Banc of California Inc (BANC) is Trading Higher on Unusual Volume for December 21

Equities Staff  |

Banc of California Inc (BANC) experienced unusually high volume on Dec. 21, as the stock gained 1.23% to a closing price of $14.77. The stock saw 357,487 shares trade hands over the course of the day on 2,426 trades. Given that the stock’s average daily volume over the last month has been 208,131 shares a day, this represents a pretty substantial spike over the norm.

Banc of California Inc has a P/B ratio of 1.23. It also has a P/E ratio of 12.5. The stock has traded between $15.38 and $10.18 over the last 52-weeks, its 50-day SMA is now $13.72, and its 200-day SMA $12.83.

Banc of California Inc is a is a financial holding company. It offers banking and financial services. Its services include banking services, lending services and private banking services.

Headquartered in Irvine, CA, Banc of California Inc has 1,470 employees and is currently under the leadership of CEO Steven Sugarman.

For a complete fundamental analysis analysis of Banc of California Inc, check out’s Stock Valuation Analysis report for BANC. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…